Kardio-Med Silesia – Medical Technology Park

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Welcome to Kardio-Med Silesia Site

SPMT Kardio-Med Silesia's activities in numbers included:

Nearly
000k

Nearly
0k

Over
0k

Nearly
00k

Conferences

Researchers associated with the Silesian Park of Medical Technology Kardio-Med Silesia in Zabrze are ready to join global research into xenografts.

Courses organized by the ANMAR Healthcare Academy are ongoing

ACADEMY OF HEALTH ANMAR

XII International Scientific Conference “HealthTech Innovation Conference” is already behind us!

XII International Scientific Conference “HealthTech Innovation Conference”

XIX Science Day

Supporting partners:

Partners: